Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Silence

FJ, on Feb 1st you summarized news as: "Poet will be doing what it takes to get the share price higher in order for a successful listing on the NASDAQ at a share price that Institutional Funds can buy at. In other words, uplisting from a position of strength"

On Feb 22: "Finally going to the NASDAQ where institutional investors await."

On Feb 23: "Do you realize that POET is going to list on the NASDAQ where the technical achievements and commercial production capabilities will be something that Institutional Investors embrance? Where analysts will look at the production capacity and the ownership of SPX and apply a value. Where large funds can inventory stock and where market makers are prepared to equate value."

Given your deeper understanding of processes/timelines for this industry, are you at all surprised with our first month?  Or would you say the current response is meaningless and simply too short-term to be bothered with?  Certainly nothing on the tech side has faltered, I'd guess we remain in a wonderful position on that front.  However there seemed to be a major disconnect on the expedited uplisting against implied forthcoming announcements and investment.  Most sincerely, curious if this has left you scratching your head, or if this all still falls in alignment with reasonable expectations?  

Share
New Message
Please login to post a reply